A Simulation-based Approach for Improving Utilization of Thrombolysis in Acute Brain Infarction

Background: Treatment with tissue plasminogen activator (tPA) is the most effective treatment in acute brain infarction. However, estimated worldwide treatment rates are

Saved in:
Bibliographic Details
Published in:Medical care 2013-12, Vol.51 (12), p.1101-1105
Main Authors: Lahr, Maarten M.H., van der Zee, Durk-Jouke, Luijckx, Gert-Jan, Vroomen, Patrick C.A.J., Buskens, Erik
Format: Article
Language:English
Subjects:
Acute Disease
Ambulances
Brain diseases
Brain infarction
Brief Report
Clinical trials
Computer Simulation
Efficiency, Organizational
Emergency Medical Services - organization & administration
Emergency Service, Hospital - organization & administration
Emergency transportation
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - therapeutic use
General practice
Health outcomes
Humans
Medical treatment
Modeling
Netherlands
Patient transportation
Plasminogen activators
Simulation
Simulations
Stroke
Stroke - drug therapy
Strokes
Time Factors
Tissue Plasminogen Activator - administration & dosage
Tissue Plasminogen Activator - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Treatment with tissue plasminogen activator (tPA) is the most effective treatment in acute brain infarction. However, estimated worldwide treatment rates are
ISSN:0025-7079
1537-1948
DOI:10.1097/MLR.0b013e3182a3e505